RLCC Map خريطة المركز الاقليمي لمكافحة الليشمانيا

Oct 16, 2016

ISD Connection: ISD Members Work Together to Fight Leishmaniasis in Yemen



ISD Connection
The Official Newsletter of the International Society of Dermatology Vol. 10, No. 3    Fall 2016
* The Fall 2016 issue of the ISD Connection newsletter is now available to view online: http://www.intsocderm.org/files/2016_FallNewsletter.pdf

STAYING CONNECTED

ISD Members Work Together to Fight Leishmaniasis in Yemen

As featured in the Winter 2016 ISD newsletter, ISD member Dr. Mohamed Al-Kamel (Yemen) has been working tirelessly to help leishmaniasis patients in war-torn Yemen get needed medical care and supplies to treat this widespread disease. Relying solely on donations and volunteers, Dr. Al-Kamel’s Regional Leishmaniasis Control Center (RLCC) is treating upwards of 100 leishmaniasis patients per month.
Heeding his plea for help for medical donations, ISD Executive Committee Member Dr. Dedee Murrell (Australia/UK) went to work and initiated contact with Stiefel/GSK pharmaceutical to secure the donation of a second year of free supplies of anti-leishmaniasis medication (Pentostam® injections) for Dr. Al-Kamel’s RLCC.

Although thousands of miles apart, Dr. Murrell and Dr. Al-Kamel came together in the true spirit of ISD by staying connected to help those in greatest need.

“Thanks to the ISD and particularly Dr. Dedee Murrell. The generous three-year donation of medicine to treat leishmaniasis, donated by Stiefel through the “Medicine-For-All” program, will help the countless Yemeni patients -- mostly women and children in the poorest rural areas -- who suffer from the severe physical and moral consequences of this disease. I consider the Teledermatology program of the RLCC as a model communication technology in which ISD members around the world can help one another -- even when they are thousands of miles apart -- in such a way as Dr. Murrell and I worked together to support such needy patients with the most needed item: the medicine. I am proud we put the neglected leishmaniasis disease in Yemen and its linked issues under the focus of the local and global scientific communities.”
-- Dr. Mohamed A. Al-Kamel, Founding Chair of the Regional Leishmaniasis Control Center (RLCC), Yemen

“At the EADV in Istanbul in October 2013, former ISD Executive Vice President, Luitgard Wiest, introduced me to Dr. Mohamed Al-Kamel, whom she knew from her volunteer work in Ethiopia over many years. She asked me to help him with a grant application he wanted to put in to the ILDS with the support of ISD for some diagnostic ELISA equipment for the Leishmaniasis centre he had set up. The grant application gained the support of the ISD executive committee and later turned out to be successful. Then, the idea came to me to request donation of the sodium pentogluconate (pentostam) from Stiefel/GSK. Through the Women’s Dermatological Society (WDS), I had met Charlie Stiefel, a great supporter of the WDS. At that time, I had also been working with GSK to design a new clinical trial for pemphigus. Through these connections, I reached the right person at GSK-Stiefel and wrote a request letter in November 2013 for a compassionate supply of $10,000 per year for 3 years, signed by Drs. Kerdel, Handog, Reizner and myself, on behalf of ISD. Not only did GSK agree, but they promised $30,000 worth of pentostam for 3 years, which is enough to treat about 2,000 patients per year. This is one example of how ISD can assist its members in poorer countries gain access to medications for needy patients.”
-- Dr. Dedee Murrell, Chair, ISD Communications Committee



* For the fall article and other stories, The Fall 2016 issue of the ISD Connection newsletter is now available to view online: http://www.intsocderm.org/files/2016_FallNewsletter.pdf